Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News

News :

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors 
The feature you requested does not exist. However, we suggest the following feature:

A.I.S. Resources Announces Financing And Contract Renegotiation

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/21/2017 | 03:51pm CEST

(via TheNewswire)

Vancouver, British Columbia - AUGUST 21, 2017 - A.I.S. Resources Limited (TSX - NEX: AIS.H, OTCQB:AISSF) (the "Company" or "AIS") announces the expiry of its original contract with Ekeko SA. The Company is negotiating with Ekeko for an additional option for a period of twelve months.

AIS also announcesa non-brokered private placement of up to 12.5 million units of the Company at a price of $0.20 per unit for gross proceeds of up to $2.5 million.

Each unit will consist of one common share and one transferrable share purchase warrant. Each warrant will entitle the holder thereof to purchase one additional common share for a period of 12 months from the closing date of the offering at a price of $0.30 per common shareprovided that if the closing price of the common shares of the Companyon any stock exchange or quotation system on which the common shares are then listed or quotedis equal to or greater than $0.45 for a period of fifteen (15) consecutive trading days, the Company will have the right to accelerate the expiry of the warrants to a date that is not less than ten (10) business days from the date notice is given.The Company will pay up to 7% finders fees and 7% finders warrants.

On Behalf of the Board of Directors,

A.I.S. Resources Limited

Marc Enright-Morin

President and CEO

About A.I.S. Resources

A.I.S Resources Limited a TSX-V listed investment issuer, was established in 1967 and is managed by experienced, highly qualified professionals who have a long track record of success in lithium exploration, production and capital markets. Through their extensive business and scientific network, they identify and develop early stage projects worldwide that have strong potential for growth with the objective of providing significant returns for shareholders. The Company's most recent activities have been the exploration of lithium properties in Northern Argentina.

Contact

A.I.S. Resources Limited

Marc Enright-Morin

President and CEO

T: 778-892-5455

E:memorin@aisresources.com

W: www.aisresources.com

ADVISORY:This press release contains forward-looking statements. More particularly, this press release contains statements concerning the anticipated use of the proceeds of the Private Placement. Although the Corporation believes that the expectations reflected in these forward-looking statements are reasonable, undue reliance should not be placed on them because the Corporation can give no assurance that they will prove to be correct. Since forward-lookingstatements address future events and conditions, by their very nature they involve inherent risks and uncertainties. The intended use of the proceeds of the Private Placement by the Corporation might change if the board of directors of the Corporation determines that it would be in the best interests of the Corporation to deploy the proceeds for some other purpose. The forward-looking statements contained in this press release are made as of the date hereof and the Corporation undertakes no obligations to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Copyright (c) 2017 TheNewswire - All rights reserved.

Copyright (c) 2017 TheNewswire - All rights reserved., source Press Releases

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news
03:51p A.I.S. Resources Announces Financing And Contract Renegotiation
03:51p BUSCAR : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
03:50p GALECTIN THERAPEUTICS : Clarification - Galectin Therapeutics Reports 2017 Second Quarter Financial Results and Provides Business Update
03:50p SAUDI TELECOM SJSC : Arabia Prepares to Launch Forum to Support SMEs
03:50p RITTER PHARMACEUTICALS : Announces Phase 3 Plans after its End of Phase 2 Meeting with FDA on RP G28 for Lactose Intolerance
03:50p MIMEDX : Provides Update on Litigation with Terminated Employees
03:50p LIGAND PHARMACEUTICALS : to Receive $2 Million from WuXi Biologics for Licensing Clinical-Stage anti PD 1 Antibody Discovered Using the OmniAb Technology
03:50p MITHRA PHARMACEUTICALS : Announces First Subject Completes Estelle Phase III Study
03:50p MIMEDX : Signs Definitive Agreement to Divest Stability Biologics Subsidiary as Part of Company's Strategic Focus on Biopharma
03:50p Jazz Pharmaceuticals Announces Offering of $500 Million of 1.50% Exchangeable Senior Notes due 2024
Latest news
Advertisement